Loading clinical trials...
Loading clinical trials...
Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? A Clinical, Prospective, Randomized, Blinded Examination of Patients Suffering From Hematological Malignancies Treated With Intensive Chemotherapy and/or Radiotherapy.
Conditions
Interventions
Bismuth tablets
Placebo tablets
Locations
1
Denmark
Department of Haematology L, Herlev Hospital, Herlev Ringvej 75
Herlev, Denmark
Start Date
May 1, 2009
Primary Completion Date
January 1, 2012
Completion Date
February 1, 2013
Last Updated
September 10, 2013
NCT02269592
NCT07122674
NCT06281496
NCT03802773
NCT06834412
NCT06150469
Lead Sponsor
Copenhagen University Hospital at Herlev
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions